Avondale Partners Downgrades Kindred Healthcare (KND) to Market Perform

Avondale Partners downgraded Kindred Healthcare (NYSE: KND) from Market Outperform to Market Perform with a price target of $14.00 (from $16.00).

For an analyst ratings summary and ratings history on Kindred Healthcare click here. For more ratings news on Kindred Healthcare click here.

Shares of Kindred Healthcare closed at $12.76 yesterday.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Hesai (2525:HK) (HSAI) PT Lowered to HK$24.20 at Macquarie
• Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'